University of Wisconsin–Madison

Researchers and Laboratories

Researchers and Laboratories

E. Jason Abel, MD, FACS

Associate Professor (CHS)

abel@urology.wisc.edu

(608) 263-4563

Dr. Abel conducts clinical, translational, and basic research in urologic oncology. Clinical and translational interests include improving patient outcomes after complex urologic surgery, improving prognostic ability for patient decision making, and multidisciplinary care of kidney cancer.

Dr. Abel serves on the board of directors for the Society of Urologic Oncology (SUO) Clinical Trials Consortium.

Sara Best, MD

Associate Professor (CHS)

best@urology.wisc.edu

(608) 263-9534

Dr. Best’s research interests lie in the study of kidney cancer and disease using optics, the development of new technology for minimally invasive surgery, and urinary stone disease.

Dale E. Bjorling, DVM

O’Brien Center Co-Director; Associate Dean of Research School; of Veterinary Medicine

Professor of Surgical Sciences

bjorling@wisc.edu

(608) 263-4808

Inflammation of the bladder due to non-infectious causes, and mechanisms that modulate pain sensation and bladder healing. The laboratory’s primary research emphasis is the causes and pathogenesis of non-infectious cystitis and and the effects of infectious cystitis on the afferent nervous system. Clinical disorders of particular relevance to models used in the laboratory include urinary tract infection, Interstitial Cystitis (IC) in women, and Feline Urologic Syndrome (FUS) in cats. The goalsof this research are to identify processes that promote inflammation, damage, and pain within the bladder and to investigate improved therapeutic modalities for treatment or prevention of symptoms assocated with cystitis.

Tudor Borza, MD, MS

Assistant Professor

borza@urology.wisc.edu

(608) 262-5440

Dr. Borza is a health services researcher with a focus is on understanding how health policy changes impact surgical care and, more specifically, care of urologic malignancies. His current projects revolve around improving opioid medication stewardship by engaging surgeons through the Surgical Collaborative of Wisconsin. Additionally, he is working on understanding how different components of the Affordable Care Act have impacted treatment patterns and readmissions among patients undergoing major surgical procedures.

Dr. Bruskewitz is studying surgical and pharmacological therapies for benign prostatic hyperplasia, with funding from the National Insitutes of Health, major pharmaceutical companies, and various study groups.

Wade A. Bushman, MD, PhD

Vice Chair for Research and Academic Affairs; Professor of Urology; Robert F. and Dolores K. Schnoes Chair in Urologic Research

Specialties: Benign Prostatic Hyperplasia (BPH), Female Urology and Voiding Dysfunction

bushman@urology.wisc.edu

(608) 262-5440

Dr. Bushman’s research interests include clinical research in bladder and pelvic floor dysfunction and basic research in prostate development and prostate cancer.

Dr. Bushman’s Lab

Dr. Downs has a joint appointment with the UW Carbone Cancer Center, and his clinical research emphasizes developing new therapies for genitourinary cancers.

Research Focus
Chemoprevention – Bladder cancer, prostate cancer
Screening Programs – Bladder cancer screening for high-risk subjects
Outcomes Research – Patient outcomes of treatments for non-muscle invasive (superficial) bladder cancer and radical cystectomy
Translational Research – Discovery of molecular and urinary biomarkers (bladder cancer)
Quality of Life Outcomes – Bladder cancer, prostate cancer

David F. Jarrard, MD

Vice Chair for Clinical Affairs; Professor of Urology; John Livesey Chair in Urologic Oncology; Associate Director, UW Carbone Cancer Center

Specialties: Minimally Invasive Urologic Surgery, Urologic Oncology

jarrard@urology.wisc.edu

(608) 262-0759

Dr. Jarrard has a joint appointment with the University of Wisconsin Comprehensive Cancer Center, and his clinical research emphasizes developing novel diagnostics and new therapies for genitourinary cancers. He has an active basic science laboratory and is funded through the National Institutes of Health and Department of Defense to examine genetic and epigenetic alterations in prostate cancer.

Dr. Jarrard’s lab

Alison C. Keenan, MD

Assistant Professor (CHS)

keenan@urology.wisc.edu

(608) 263-0720

Dr. Keenan’s research interests include minimally invasive surgery outcomes, nephrolithiasis, modern techniques for surgical education, and applications of decisional sciences to pediatric urology practices.

Christopher M. Manakas, MD

Assistant Professor (CT)

manakas@wisc.edu

(608) 263-9534

Clinical Informatics
Quality Improvement

Sarah E. McAchran, MD, FACS

Associate Professor (CHS)

mcachran@urology.wisc.edu

(608) 263-4563

Dr. McAchran’s research interests in female urology include optimization of care pathways to improve surgical outcomes and clinical outcomes of female pelvic floor reconstruction.

Stephen Y Nakada, MD, FACS, FRCS (Glasg.)

Chairman, Department of Urology; The David T. Uehling Chair in Urology

Specialties: Minimally Invasive Urologic Surgery, Stone Disease

nakada@urology.wisc.edu

(608) 263-1359

Dr. Nakada’s research focuses on pathophysiology of the ureter and all aspects of urinary stone disease. His research is currently supported by the American Urologic Association.

Click here for the Wisconsin Stone Quality of Life Questionnaire (WISQOL).

Recent Features

Dr. Nakada featured in Endourology Sound Bites

David R. Paolone, MD

Vice Chair for Regional Urology; Associate Professor (CHS)

Specialties: Benign Prostatic Hyperplasia (BPH), Male Factor Infertility and Sexual Health, Minimally Invasive Urologic Surgery

david.paolone@uwmf.wisc.edu

(608) 287-2900

Dr. Paolone’s research interests are in the areas of Benign Prostate Hyperplasia (BPH) and penile disorders.

Kristina Penniston, PhD

Senior Scientist

penn@urology.wisc.edu

(608) 265-9797

Dr. Penniston’s research interests include clinical nutrition research in kidney stones and prostate cancer. Specifically, she is interested in the efficacy of nutrition therapy in the prevention, management, and treatment of disease and on indicators of quality of life.

Click here for the Wisconsin Stone Quality of Life Questionnaire (WISQOL).

Kyle A. Richards, MD, FACS

Assistant Professor (CHS)

richardsk@urology.wisc.edu

(608) 262-0759

Dr. Richards conducts clinical, translational and health services research in urologic oncology. He has special interests in quality improvement projects aimed at streamlining health care delivery and efficiency for all patients with urologic malignancies.

William Ricke, PhD

O’Brien Center Director; UWMF-Professor of Urologic Research Director of Research

rickew@urology.wisc.edu

(608) 265-3202

Dr. Ricke’s research interests include prostate cancer.

Ricke Lab

Ruthie Su, MD

Assistant Professor (CHS)

su@urology.wisc.edu

(608) 263-0720

Dr. Su’s research interests include urinary tract infections, disorders of sexual development, outcomes analysis of complex urologic reconstruction, clinical epidemiology, and translational science.

Daniel H. Williams IV, MD

Vice Chair for Education; Urology Residency Program Director; Associate Professor (CHS); UWMF Professor in Clinical Urology

Specialties: Benign Prostatic Hyperplasia (BPH), Male Factor Infertility and Sexual Health

williams@urology.wisc.edu

(608) 263-4563

Dr. Williams’ research interests in male infertility include the preservation of fertility in men with cancer, the effects of advanced paternal age and the environment on male reproductive potential, and clinical outcomes of male reproductive tract reconstructions.